chr3-47004356-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP3BP4_StrongBP6_Very_StrongBA1

The NM_015175.3(NBEAL2):​c.6161C>T​(p.Ser2054Phe) variant causes a missense change. The variant allele was found at a frequency of 0.164 in 1,602,398 control chromosomes in the GnomAD database, including 22,934 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.14 ( 1827 hom., cov: 32)
Exomes 𝑓: 0.17 ( 21107 hom. )

Consequence

NBEAL2
NM_015175.3 missense

Scores

9
3
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 5.90

Publications

40 publications found
Variant links:
Genes affected
NBEAL2 (HGNC:31928): (neurobeachin like 2) The protein encoded by this gene contains a beige and Chediak-Higashi (BEACH) domain and multiple WD40 domains, and may play a role in megakaryocyte alpha-granule biogenesis. Mutations in this gene are a cause of gray platelet syndrome. [provided by RefSeq, Dec 2011]
NBEAL2 Gene-Disease associations (from GenCC):
  • gray platelet syndrome
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a domain BEACH (size 292) in uniprot entity NBEL2_HUMAN there are 8 pathogenic changes around while only 3 benign (73%) in NM_015175.3
PP3
Multiple lines of computational evidence support a deleterious effect 7: AlphaMissense, BayesDel_noAF, Cadd, Eigen, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.0017380118).
BP6
Variant 3-47004356-C-T is Benign according to our data. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-47004356-C-T is described in CliVar as Benign. Clinvar id is 260587.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NBEAL2NM_015175.3 linkc.6161C>T p.Ser2054Phe missense_variant Exon 37 of 54 ENST00000450053.8 NP_055990.1 Q6ZNJ1-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NBEAL2ENST00000450053.8 linkc.6161C>T p.Ser2054Phe missense_variant Exon 37 of 54 2 NM_015175.3 ENSP00000415034.2 Q6ZNJ1-1

Frequencies

GnomAD3 genomes
AF:
0.137
AC:
20874
AN:
151822
Hom.:
1826
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0409
Gnomad AMI
AF:
0.166
Gnomad AMR
AF:
0.150
Gnomad ASJ
AF:
0.0980
Gnomad EAS
AF:
0.224
Gnomad SAS
AF:
0.0929
Gnomad FIN
AF:
0.243
Gnomad MID
AF:
0.114
Gnomad NFE
AF:
0.175
Gnomad OTH
AF:
0.160
GnomAD2 exomes
AF:
0.155
AC:
37011
AN:
239496
AF XY:
0.154
show subpopulations
Gnomad AFR exome
AF:
0.0368
Gnomad AMR exome
AF:
0.121
Gnomad ASJ exome
AF:
0.0980
Gnomad EAS exome
AF:
0.228
Gnomad FIN exome
AF:
0.237
Gnomad NFE exome
AF:
0.173
Gnomad OTH exome
AF:
0.172
GnomAD4 exome
AF:
0.166
AC:
241344
AN:
1450458
Hom.:
21107
Cov.:
38
AF XY:
0.164
AC XY:
118281
AN XY:
720286
show subpopulations
African (AFR)
AF:
0.0370
AC:
1235
AN:
33338
American (AMR)
AF:
0.127
AC:
5638
AN:
44270
Ashkenazi Jewish (ASJ)
AF:
0.0914
AC:
2308
AN:
25250
East Asian (EAS)
AF:
0.219
AC:
8653
AN:
39594
South Asian (SAS)
AF:
0.0977
AC:
8271
AN:
84646
European-Finnish (FIN)
AF:
0.234
AC:
12318
AN:
52550
Middle Eastern (MID)
AF:
0.134
AC:
765
AN:
5720
European-Non Finnish (NFE)
AF:
0.174
AC:
192826
AN:
1105166
Other (OTH)
AF:
0.156
AC:
9330
AN:
59924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
12526
25052
37579
50105
62631
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6740
13480
20220
26960
33700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.137
AC:
20867
AN:
151940
Hom.:
1827
Cov.:
32
AF XY:
0.140
AC XY:
10385
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.0408
AC:
1694
AN:
41470
American (AMR)
AF:
0.150
AC:
2288
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.0980
AC:
340
AN:
3470
East Asian (EAS)
AF:
0.224
AC:
1151
AN:
5132
South Asian (SAS)
AF:
0.0927
AC:
446
AN:
4810
European-Finnish (FIN)
AF:
0.243
AC:
2561
AN:
10550
Middle Eastern (MID)
AF:
0.119
AC:
35
AN:
294
European-Non Finnish (NFE)
AF:
0.175
AC:
11867
AN:
67920
Other (OTH)
AF:
0.158
AC:
334
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
874
1749
2623
3498
4372
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
234
468
702
936
1170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.157
Hom.:
2346
Bravo
AF:
0.129
TwinsUK
AF:
0.177
AC:
655
ALSPAC
AF:
0.167
AC:
644
ESP6500AA
AF:
0.0466
AC:
185
ESP6500EA
AF:
0.168
AC:
1392
ExAC
AF:
0.151
AC:
18307
Asia WGS
AF:
0.165
AC:
576
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Gray platelet syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.62
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Pathogenic
0.15
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Pathogenic
0.85
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.9
M
PhyloP100
5.9
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Pathogenic
0.72
Sift
Pathogenic
0.0
D
Polyphen
0.99
D
Vest4
0.26
MPC
1.4
ClinPred
0.036
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.83
gMVP
0.76
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305637; hg19: chr3-47045846; COSMIC: COSV52759217; COSMIC: COSV52759217; API